Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Non-Current Assets (2023 - 2025)

Onconetix (ONCO) has disclosed Non-Current Assets for 2 consecutive years, with $60.9 million as the latest value for Q3 2024.

  • On a quarterly basis, Non-Current Assets rose 231.89% to $60.9 million in Q3 2024 year-over-year; TTM through Sep 2024 was $155.0 million, a N/A change, with the full-year FY2023 number at $209196.0, changed N/A from a year prior.
  • Non-Current Assets was $60.9 million for Q3 2024 at Onconetix, up from $57.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $60.9 million in Q3 2024 to a low of $29710.0 in Q1 2023.